Paraza Pharma appointed Edward Marple, A.B. as executive vice-president, development. Marple has more than 20 years of experience as a senior executive with broad skill sets across clinical development, IP protection, manufacturing, operations, company and product strategy, finance, and commercial partnering/development in the biotechnology and pharmaceutical industry.

“We are excited to have Ted join Paraza’s senior leadership team as we continue to expand our capabilities to better serve our client-partners,” said Arshad Siddiqui, Founder and CEO of Paraza.  “Ted’s extensive business and commercial expertise will be invaluable to Paraza as we continue to partner with biotechnology and pharmaceutical companies to accelerate research, development and access to new and better treatments for patients.”

“I am delighted by the opportunity to join Arshad and collaborate with the Paraza team as they continue to grow and expand Paraza’s ability to deliver wonderful science and innovative drug discovery solutions to their client-partners,” said Marple.